搜尋結果
Mycophenolate mofetil trumps azathioprine for remission in treatment-naive autoimmune hepatitis. 16 Apr 2024. Inverse relationship between obesity, aortic pressure augmentation inhibited in women. 16 Apr 2024. Retrievable tPA-anchored nanorobots may improve thrombolysis in ischaemic stroke. 16 Apr 2024.
Search drug information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia and India Register for a MIMS account and ...
2021年3月9日 · Haematologists from the University of Hong Kong (HKU) have reported initial success with chimeric antigen receptor (CAR) T-cell therapy, treating the first patient in Hong Kong in May 2020 in a global lymphoma trial and another leukaemia patient in October 2020 in a real-world clinical practice setting.
Praluent Dosage & Drug Information | MIMS Hong Kong. MIMS home. Drugs. Info. Praluent. alirocumab. Sanofi. DCH Auriga - Healthcare. / Four Star. Concise Prescribing Info. Contents. Alirocumab. Indications/Uses. Reduces risk of MI, stroke, & unstable angina requiring hospitalization in adults w/ established CV disease.
MIMS.com is the leading online source of drug information, interactions, images, dosage and side effects for healthcare professionals in Malaysia and beyond. Whether you are looking for the latest medical news, updates on clinical guidelines, or comprehensive drug databases, MIMS.com has it all. Join millions of users who trust MIMS.com as their essential medical reference.
Concise Prescribing Info. Contents. Proteolytic peptide fraction from porcine brain protein. Indications/Uses. Cerebral cerebro-organically induced metabolic disorders, in particular Alzheimer-type senile dementia; post apoplectic defunctionalization symptoms; cranio-cerebral traumata (commotio & contusio, surgical cranial interventions).
SANDOZ HONG KONG LIMITED. Sandoz is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical need. Our ambition is to be the world's leading and most valued generics company.
